WideCells Group PLC CellPlan partnership agreement with Smart Cells

WideCell’s CEO, João Andrade, said, “We are delighted to be working closely with Smart Cells, which is a well-established and respected global company, to enhance its offering with our unique stem cell treatment insurance plan and increase CellPlan’s own profile worldwide. This is a seminal deal for CellPlan, in line with our corporate strategy focused on building revenue growth and delivering accessible and affordable cell treatments to more people.”

WideCells Group PLC (LON:WDC), the healthcare services group focused on providing stem cell services and ground-breaking insurance for stem cell treatment, today announced that its stem cell healthcare insurance subsidiary, CellPlan, has signed a partnership agreement with a leading international stem cell extraction and storage company, Smart Cells.

Under the terms of the agreement, Smart Cells, which has offices in Europe, Africa, Middle East, Asia and the Far East, will offer CellPlan’s innovative insurance plan to its 60,000 clients across multiple geographies. The staged roll-out will commence in Spain within the next four weeks, followed by the UK and then worldwide. With CellPlan operations already in place in Spain and the UK CellPlan can commence stem cell insurance sales soon, unlocking revenue from Smart Cell’s existing and new client base.

Smart Cells CEO, Shamshad Ahmed, said, “I believe that this partnership will be mutually beneficial for both companies and especially useful for our clients all over the world.  I look forward to cooperating with CellPlan and working together on the global rollout of re-enhanced services.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Umbilical blood injects new life into 8-month-old baby

    An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery in Shanghai. The stem cell was taken from umbilical cord blood. Widecells Group PLC (LON:WDC) are leading a

    WideCells Group PLC

    Leukaemia: A Guide To The Cancer Of The Blood

    It is not hereditary, and it is not contagious. It is, however, one of the diseases that kills more children than many others. The word ‘leukaemia’ refers to a group of cancers that spread through the

    WideCells Group PLC

    Autism Treated With Stem Cells

    Researchers at Duke University have utilized autologous (the patient’s own) stem cell infusions to promote increased connectivity in the brain that allowed for improved communication and language abilities in children with Autism Spectrum Disorder (ASD). The

    WideCells Group PLC

    Cord blood banking industry expected to grow

    The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare. Many private companies offer services for collecting and storing